Skip to main content
. 2023 Feb 3;37(1):70–81. doi: 10.3341/kjo.2022.0125

Fig. 2.

Fig. 2

Reduction of myopia progression (RMP) expressed as the percentage of sphere equivalent decrease. A 3-year study: (A) dual-focus MiSight 1 day (CooperVision) and (B) multifocal Biofinity (CooperVision) contact lenses. A 2-year study: extended depth of focus (C) Mylo (Mark’ennovy) and (D) 1dayPure (SEED) contact lenses. A 3-year study: (E) single vision MiyoSmart (Hoya), (F) multifocal Myopilux (Essilor), (G) single vision Stellest (Essilor), and (H) single vision MyoVision (Zeiss) spectacle lenses.